Table 4.
Preclinical studies using retargeted attenuated measles virus.
Target disease | Transgenic expressed proteins | Targeted receptor and cells | Administration route | Preclinical assay | Parental strain | Receptors used for viral entry | References |
---|---|---|---|---|---|---|---|
Multiple Myeloma | A disintegrin ML-28L echistatin (MV-ERV measles virus echistatin vector) | Integrin alpha(v)beta3 expressed on activated but not quiescent endothelial cells (targeting tumors and their associated blood vessels) | Intratumoral | mice | MV Edmonston B | CD150, CD46, integrin αvβ3 | 96 |
Breast cancer | Amino-terminal fragment of the urokinase plasminogen activator (uPA) (of human or mice) targeting uPAR (MV-uPA), | Urokinase receptor (uPAR) on activated endothelial cells (tumor vascular targeting) | IV | mice | Edmonston vaccine lineage NSe strain11. | uPAR, CD46, CD150 | 98 |
Non-Hodgkin's Lymphoma (NHL) | CD-20 targeted MV vector expressing the prodrug convertase purine nucleoside phosphorylase (PNP) | CD20 (B-cell specific antigen CD20) | Intracerebral administration | mice | Edmonston vaccine lineage NSe strain | CD20, (ablation of CD46 and CD150 interactions) | 99 |
Glioblastoma multiforme (GBM) | Human IL-13, GFP | Interleukin-13-receptor α2 (IL-13R α2) | Intracerebral administration | mice | Edmonston vaccine lineage NSe strain | IL-13Rα2, (ablation of CD46 and CD150 interactions) | 100 |
Glioblastoma multiforme | a single chain antibody recognizing EGFR, GFP | Epidermal growth factor receptor (EGFR) or EGFRvIII (the most common EGFR mutant) (EGFR is a glioma-specific receptor) | Intracerebral administration | mice | Edmonston vaccine lineage NSe strain | EGFR or EGFRvIII, (ablation of CD46 and CD150 interactions) | 101 |
Myeloma | Oncolytic MV displaying αvβ3 integrin-binding peptides, cyclic arginine-glycine-aspartate (RGD) or echistatin (integrins)4 recombinant MV displaying cyclic RGD or echistatin and GFP | Both viruses had expanded tropisms, and efficiently entered target cells via binding to integrinsNeovessel endothelial cells in vivo | iv | mice | cDNAs of the virulent IC-B strain isolated in a lymphoid cell line, B95a2 | CD46-CD150-EGFR | 103 |
Ovarian cancer | MV-αFV: a single-chain antibody (scFv) specific for α-folate receptor | Folate receptor | Sc, ip | Mice | Edmonston vaccine lineage NSe strain | Folate receptor (ablation of CD46 and CD150 interactions) | 104 |
The virus is derived from the Edmonston vaccine lineage NSe strain; it was rescued using the pseudoreceptor STAR (6 His tagging and retargeting) system propagated on Vero-HIS cells. The viral H protein contains the CD46-ablating mutation Y481A and the SLAM-ablatting mutation R533A. it also contains the GFP which facilitates viral rescue and allows visualization of infection in vitro and in vivo.97
The rescue system uses Chine hamster ovary cells expressing CD150 (CHO/hSLAM) and the recombinant vaccinia virus LO-T7-1 (the lister strain had been used as a vaccine in the WHO smallpox eradication programme).102